These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 8103116)
1. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. Frim DM; Simpson J; Uhler TA; Short MP; Bossi SR; Breakefield XO; Isacson O J Neurosci Res; 1993 Jul; 35(4):452-8. PubMed ID: 8103116 [TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats. Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615 [TBL] [Abstract][Full Text] [Related]
3. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988 [TBL] [Abstract][Full Text] [Related]
4. Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Frim DM; Wüllner U; Beal MF; Isacson O Exp Neurol; 1994 Aug; 128(2):172-80. PubMed ID: 8076661 [TBL] [Abstract][Full Text] [Related]
5. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid. Duan W; Guo Z; Mattson MP Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480 [TBL] [Abstract][Full Text] [Related]
6. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. Lagoa R; Lopez-Sanchez C; Samhan-Arias AK; Gañan CM; Garcia-Martinez V; Gutierrez-Merino C J Neurochem; 2009 Oct; 111(2):473-87. PubMed ID: 19682208 [TBL] [Abstract][Full Text] [Related]
7. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Frim DM; Uhler TA; Short MP; Ezzedine ZD; Klagsbrun M; Breakefield XO; Isacson O Neuroreport; 1993 Apr; 4(4):367-70. PubMed ID: 8098961 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways. Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163 [TBL] [Abstract][Full Text] [Related]
9. 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate. Storgaard J; Kornblit BT; Zimmer J; Gramsbergen JB Exp Neurol; 2000 Jul; 164(1):227-35. PubMed ID: 10877933 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes. Singh S; Misiak M; Beyer C; Arnold S Glia; 2009 Nov; 57(14):1480-91. PubMed ID: 19306371 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats. Binienda Z; Virmani A; Przybyla-Zawislak B; Schmued L Neurosci Lett; 2004 Sep; 367(2):264-7. PubMed ID: 15331167 [TBL] [Abstract][Full Text] [Related]
13. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats. Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966 [TBL] [Abstract][Full Text] [Related]
14. Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion? Del Río P; Montiel T; Chagoya V; Massieu L Neuroscience; 2007 Jun; 146(4):1561-70. PubMed ID: 17490821 [TBL] [Abstract][Full Text] [Related]
15. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions. Maragos WF; Jakel RJ; Pang Z; Geddes JW Exp Neurol; 1998 Dec; 154(2):637-44. PubMed ID: 9878198 [TBL] [Abstract][Full Text] [Related]
16. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice. Alexi T; Hughes PE; Knüsel B; Tobin AJ Exp Neurol; 1998 Sep; 153(1):74-93. PubMed ID: 9743569 [TBL] [Abstract][Full Text] [Related]
17. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease. Park JE; Lee ST; Im WS; Chu K; Kim M Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum. Simpson JR; Isacson O Exp Neurol; 1993 May; 121(1):57-64. PubMed ID: 8495711 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Kim JH; Kim S; Yoon IS; Lee JH; Jang BJ; Jeong SM; Lee JH; Lee BH; Han JS; Oh S; Kim HC; Park TK; Rhim H; Nah SY Neuropharmacology; 2005 Apr; 48(5):743-56. PubMed ID: 15814108 [TBL] [Abstract][Full Text] [Related]
20. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease. Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]